BACKGROUND: Modification of the heparin binding site by alteration of the amino acid sequence of bone morphogenetic protein-2 (BMP-2) results in a change in the local retention time. The purpose of this study was to compare the osteogenic activity of T3 and T4, two mutants with increased binding capacity to heparin, and B2GDF-5 a mutant resulting from the fusion of the n-terminal amino acid sequence of BMP-2 and the c-terminal sequence of GDF-5 with wild-type BMP-2 in vivo. MATERIAL AND METHODS: The proteins were coupled to an equine-derived collagen carrier and implanted in standardized critical size calvarial defects in adult rats. After 28 days, bone formation was evaluated radiographically and the new bone was characterized histologically. RESULTS: Proteins T3 and T4 showed a higher osteogenic activity than BMP-2. Less new bone formation was observed with GDF-5 and B2GDF-5 than with-type BMP-2. No difference in bone formation was observed between GDF-5 and B2GDF-5. CONCLUSION: Increased heparin binding capacity enhances osteogenic activity of BMP-2 in vivo. This might be due to a longer retention period in the tissue and thus better bioavailability. Replacement of the N-terminal amino acid sequence of GDF-5 by the corresponding sequence of BMP-2 did not result in an increased osteogenic activity as heparin binding capacity is not the main reason for the bioavailability of GDF-5.
BACKGROUND: Modification of the heparin binding site by alteration of the amino acid sequence of bone morphogenetic protein-2 (BMP-2) results in a change in the local retention time. The purpose of this study was to compare the osteogenic activity of T3 and T4, two mutants with increased binding capacity to heparin, and B2GDF-5 a mutant resulting from the fusion of the n-terminal amino acid sequence of BMP-2 and the c-terminal sequence of GDF-5 with wild-type BMP-2 in vivo. MATERIAL AND METHODS: The proteins were coupled to an equine-derived collagen carrier and implanted in standardized critical size calvarial defects in adult rats. After 28 days, bone formation was evaluated radiographically and the new bone was characterized histologically. RESULTS: Proteins T3 and T4 showed a higher osteogenic activity than BMP-2. Less new bone formation was observed with GDF-5 and B2GDF-5 than with-type BMP-2. No difference in bone formation was observed between GDF-5 and B2GDF-5. CONCLUSION: Increased heparin binding capacity enhances osteogenic activity of BMP-2 in vivo. This might be due to a longer retention period in the tissue and thus better bioavailability. Replacement of the N-terminal amino acid sequence of GDF-5 by the corresponding sequence of BMP-2 did not result in an increased osteogenic activity as heparin binding capacity is not the main reason for the bioavailability of GDF-5.
Authors: E A Wang; V Rosen; J S D'Alessandro; M Bauduy; P Cordes; T Harada; D I Israel; R M Hewick; K M Kerns; P LaPan Journal: Proc Natl Acad Sci U S A Date: 1990-03 Impact factor: 11.205
Authors: L Erlacher; J McCartney; E Piek; P ten Dijke; M Yanagishita; H Oppermann; F P Luyten Journal: J Bone Miner Res Date: 1998-03 Impact factor: 6.741
Authors: Julian Lommen; Michael Sus; Karin Berr; Norbert R Kübler; Fabian Langenbach; Christoph Sproll; Max Wilkat; Felix Schrader; Jörg Handschel; Lara Schorn Journal: In Vivo Date: 2022 May-Jun Impact factor: 2.406
Authors: Michael Schneider; André C Zimmermann; Rita A Depprich; Norbert R Kübler; Rainer Engers; Christian D Naujoks; Jörg Handschel Journal: Head Face Med Date: 2009-11-24 Impact factor: 2.151
Authors: Martin Grünert; Christian Dombrowski; Murali Sadasivam; Kerry Manton; Simon M Cool; Victor Nurcombe Journal: J Mol Histol Date: 2007-08-08 Impact factor: 2.611
Authors: Ines Hasenbein; André Sachse; Peter Hortschansky; Klaus D Schmuck; Victoria Horbert; Christoph Anders; Thomas Lehmann; René Huber; Alexander Maslaris; Frank Layher; Christina Braun; Andreas Roth; Frank Plöger; Raimund W Kinne Journal: Biomedicines Date: 2022-02-21
Authors: Claudia Siverino; Shorouk Fahmy-Garcia; Didem Mumcuoglu; Heike Oberwinkler; Markus Muehlemann; Thomas Mueller; Eric Farrell; Gerjo J V M van Osch; Joachim Nickel Journal: Int J Mol Sci Date: 2022-04-01 Impact factor: 5.923
Authors: Maria Ann Woodruff; Subha Narayan Rath; Evelyn Susanto; Larisa M Haupt; Dietmar W Hutmacher; Victor Nurcombe; Simon M Cool Journal: J Mol Histol Date: 2007-09-12 Impact factor: 3.156
Authors: Julian Lommen; Lara Schorn; Alexis Landers; Henrik Holtmann; Karin Berr; Norbert R Kübler; Christoph Sproll; Majeed Rana; Rita Depprich Journal: Head Face Med Date: 2019-11-11 Impact factor: 2.151